Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TPM2 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
mRNA | CEACAM6 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | RNF149 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
mRNA | ARAP3 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
mRNA | IPO8 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | KIAA1755 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | TGM5 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | ATP13A4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | CYP7B1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | S100A2 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |